Novo Nordisk A/S | Kostnadene For Salg



Cost Of Sales Endring Dato
Bausch Health Companies USD 696M 23M 2024-09
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Merck USD 3.71B 181M 2024-12
Novartis USD 3.32B 90M 2024-12
Novo Nordisk 11.31B 1.03B 2024-09
Novo Nordisk DKK 11.31B 1.03B 2024-09
Pacira USD 39.89M 1.02M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Supernus Pharmaceuticals USD 17.2M 385K 2024-12



Novo Nordisk A/S Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.